Onconaut Therapeutics, Inc.

Biotechnology company · Aurora, Colorado, United States

Onconaut Therapeutics, Inc. is a biotechnology company headquartered in Aurora, Colorado, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $400,000 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Onconaut Therapeutics at a glance

Typebiotechnology company
HeadquartersAurora, Colorado, United States
Earliest incorporation on record2022
Employees (self-reported, 2025)4
SEC CIK2042684

What does Onconaut Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $400,000 in total (2025). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $125,000 sold (2024).

Frequently asked questions about Onconaut Therapeutics

Where is Onconaut Therapeutics headquartered?

Onconaut Therapeutics, Inc. is headquartered in Aurora, Colorado, United States.

What does Onconaut Therapeutics do?

Onconaut Therapeutics, Inc. is a biotechnology company.

When was Onconaut Therapeutics founded?

The earliest incorporation on record for Onconaut Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences